SCHEMBL23501693

SCHEMBL23501693

Cc1ncc(C(=O)O)cc1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 4/20 0.44
KDM4E B2RXH2 4/20 0.41
POLB P06746 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
CTDSP1 Q9GZU7 2/20 0.41
HTT P42858 1/20 0.41
CASP6 P55212 1/20 0.41
TDP1 Q9NUW8 3/20 0.41
ALDH1A1 P00352 4/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MGAM O43451 1/20 0.40
CYP19A1 P11511 1/20 0.39
P4HA1 P13674 2/20 0.38
P4HTM Q9NXG6 2/20 0.38
APEX1 P27695 2/20 0.38
ERN1 O75460 1/20 0.38
TPMT P51580 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23501601 0.78 CYP2C9 (0.50) KDM4EPOLBL3MBTL1ALDH1A1CYP2C9
SCHEMBL17803461 0.78 HCAR2 (0.44) HCAR2KDM4EPOLBALDH1A1ALOX15
SCHEMBL846024 0.76 HCAR2 (0.50) HCAR2KDM4EPOLBTDP1ALDH1A1
Formamide SCHEMBL28252276 0.75 KDM4E (0.45) HCAR2KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL4140207 0.75 AGBL2 (0.41) HCAR2KDM4EALDH1A1ERN1MEN1
SCHEMBL4121189 0.75 HCAR2 (0.48) HCAR2KDM4EPOLBL3MBTL1TDP1
SCHEMBL9504528 0.75 HCAR2 (0.48) HCAR2KDM4EPOLBTDP1ALDH1A1
SCHEMBL6052889 0.75 HCAR2 (0.48) HCAR2KDM4ETDP1ALDH1A1ALOX15
SCHEMBL30668508 0.75 HCAR2 (0.48) HCAR2KDM4ETDP1ALDH1A1ALOX15
SCHEMBL6626617 0.74 ERN1 (0.46) KDM4EALDH1A1ERN1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021117846-A1 COMPOUND SERVING AS PDGF RECEPTOR KINASE INHIBITOR, AND COMPOSITION 日本新薬株式会社 2021-06-17 WO disclosed